Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neck Dissection Stratification for HPV+ Oropharyngeal Cancer
NCT02784288Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Oct 2016
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in oropharyngeal squamous cell carcinoma (OPSCC), sponsored by University of Michigan Rogel Cancer Center. Primary endpoint: Median Change in Quality of Life (QOL) From Baseline to 12 Months Post Treatment. Started Oct 2016; status: completed.
02
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)
Beyond the preview
Go deeper on NCT02784288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02784288.